inhaled insulin Afrezza
Selected indexed studies
- Technosphere inhaled insulin (Afrezza). (Drugs Today (Barc), 2014) [PMID:25588086]
- Technosphere insulin (Afrezza): a new, inhaled prandial insulin. (Ann Pharmacother, 2015) [PMID:25313261]
- An inhaled insulin (Afrezza). (Med Lett Drugs Ther, 2015) [PMID:25719998]
_Worker-drafted node — pending editorial review._
Connections
inhaled insulin Afrezza is a side effect of
Sources
- Recent Advances in Insulin Therapy. (2020) pubmed
- Technosphere inhaled insulin (Afrezza). (2014) pubmed
- Technosphere insulin (Afrezza): a new, inhaled prandial insulin. (2015) pubmed
- An inhaled insulin (Afrezza). (2015) pubmed
- Recommendations for Initiating Use of Afrezza Inhaled Insulin in Individuals with Type 1 Diabetes. (2018) pubmed
- Afrezza: An inhaled approach to insulin delivery. (2015) pubmed
- An inhaled insulin (Afrezza). (2015) pubmed
- Afrezza inhaled insulin: the fastest-acting FDA-approved insulin on the market has favorable properties. (2014) pubmed
- Technosphere insulin: inhaled prandial insulin. (2016) pubmed
- Inhaled Insulin - Current Direction of Insulin Research. (2017) pubmed